Eli Lilly's Emgality didn’t outdo Pfizer’s Nurtec in the prevention of migraines in a head-to-head trial.

Eli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three Teva patents, a Boston federal court ...

A U.S. judge has sided with Lilly, overturning a $176.5M jury verdict awarded to Teva in a patent infringement squabble over competing migraine drugs.

Eli Lilly and Company LLY announced that the FDA has granted approval to its CGRP antibody, Emgality injection (300 mg) for the preventive treatment of episodic cluster headache in adult patients.

Emgality is administered via injection, and Nurtec ODT is administered orally. In CHALLENGE-MIG, the safety profiles of Emgality and Nurtec ODT were consistent with those previously reported for ...

Risks and uncertainties that may affect Organon’s future results include, but are not limited to, an inability of Organon to fully execute on its commercialization plan for Emgality® and/or an ...

The injection is given once a month ... approved for adults in 2018 and competes with similar drugs such as Amgen's Aimovig and Eli Lilly's Emgality. (Reporting by Padmanabhan Ananthan in Bengaluru; ...

If Eli Lilly and Co. had been hoping its migraine drug, Emgality (galcanezumab), would emerge with unequivocal superiority against Pfizer Inc.’s Nurtec ODT (rimegepant orally disintegrating tablet), ...

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs ...

The two companies have been battling for years over patents for migraine headache drugs—Emgality for Lilly and Anjovy for Teva. Both drugs are once-monthly injections and were approved 13 days ...

Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that found Lilly's migraine drug Emgality infringed ...

Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading to millions in improper Medicaid claims.